Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...
More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
It could be a medical condition called essential tremor, and a new study by Singapore’s National Neuroscience Institute has ...
Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...
A new drug molecule could reactivate housekeeping functions in the brain cells of young Parkinson's patients, paving the way ...
The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
Guided subthalamic nucleus deep brain stimulation programming for Parkinson disease,” published in the September 2024 issue ...
Moderate- or high-intensity exercise can help with Parkinson's disease symptoms like fatigue, a recent study shows.
Paraquat exposure and its link to Parkinson’s disease is leading to policy battles within California and nationwide.